Common Names
Geographic Range: Europe, Central Asia, North Africa; naturalized worldwide in temperate zones
Known Contraindications
1
Compounds
3
Traditions
3
Treatments
3
Conditions
OC[C@@H]1OC(Oc2ccccc2CO)[C@H](O)[C@@H](O)[C@@H]1OCYP Interaction Profile
| Enzyme | Interaction |
|---|---|
| CYP1A2 | no significant interaction |
| CYP2C9 | substrate (primary metabolism) |
| CYP2D6 | no significant interaction |
| CYP3A4 | no significant interaction |
| CYP2C19 | weak substrate |
| clinical_note | May compete with warfarin, NSAIDs, methotrexate for CYP2C9 metabolism |